Skip to main content

Agilent Continues Aggressive Push into Microarray Market with New Facility

NEW YORK, Jan 10 - Agilent Technologies said Wednesday that it has opened its 15,000-square-foot DNA microarray production facility at its Santa Clara, Calif. site, five months after it announced plans to expand its microarray manufacturing program.

The facility significantly increases Agilent's current manufacturing capacity, and should enable it to ship over 1 million microarrays per year by 2002, the company said.

Agilent spokesman Doug Forsyth said that “people worked overtime” in order to get the facility online as quickly as possible. “Market pressure was such that we needed to pull all the stops out to get it completed,” he said.

Forsyth noted that the new facility is a critical development in the company’s plans to begin producing catalog arrays. While Agilent currently manufactures custom arrays to customer specifications, catalog arrays will be off-the-shelf products available to anyone who wants to buy them, Forsyth said.

Agilent’s licensing agreement with Incyte, announced earlier this week, is another major component of the move toward catalog arrays, Forsyth said. The agreement with Incyte gives Agilent access to Incyte's clone sets.

Forsyth said he expects production of catalog arrays to begin in the early summer.
The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.